Research programme: HIV vaccine - AriaVax
Latest Information Update: 22 Oct 2009
At a glance
- Originator AriaVax
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical HIV infections
Most Recent Events
- 22 Oct 2009 Preclinical development is ongoing in US
- 05 Feb 2007 Preclinical trials in HIV infections treatment in USA (Parenteral)